# PROTO SCRIPT PHARMACEUTICAL CORP

PROTO SCRIPT PHARMACEUTICAL CORP is a company headquartered in Rancho Cucamonga, CA, United States.

## Company overview

- **Legal name:** PROTO SCRIPT PHARMACEUTICAL CORP
- **Former names in filing history:** YANEX GROUP, INC. (2011-06-27 to 2016-10-06)
- **Classification:** Company
- **Industry (SIC):** 7330 — Services-Mailing, Reproduction, Commercial Art & Photography
- **Headquarters:** Rancho Cucamonga, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001521420

## About

PROTO SCRIPT PHARMACEUTICAL CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001521420, and its reported industry is Services-Mailing, Reproduction, Commercial Art & Photography. In 10-K filed on 2017-09-20, it reported annual revenue of USD 788,960; net income of USD -7,182,722; total assets of USD 170,191 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $788,960 (USD 788,960)
- **Net income:** -$7.2M (USD -7,182,722)
- **Total assets:** $170,191 (USD 170,191)
- **Cash and equivalents:** $3,507 (USD 3,507)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-05-31)

- **Net income:** -$33,143 (USD -33,143)
- **Total assets:** $11,750 (USD 11,750)
- **Cash and equivalents:** $11,750 (USD 11,750)
- **Operating cash flow:** -$38,209 (USD -38,209)

### FY2015 (period ended 2015-05-31)

- **Net income:** -$45,180 (USD -45,180)
- **Total assets:** $1,019 (USD 1,019)
- **Cash and equivalents:** $1,019 (USD 1,019)
- **Operating cash flow:** -$45,421 (USD -45,421)

### FY2014 (period ended 2014-05-31)

- **Net income:** -$38,259 (USD -38,259)
- **Total assets:** $13,540 (USD 13,540)
- **Cash and equivalents:** $13,540 (USD 13,540)
- **Operating cash flow:** -$32,504 (USD -32,504)

## Recent SEC filings

- Form 10-Q — filed 2018-03-08 — period 2017-09-30 — FORM 10-Q
- Form 10-Q — filed 2018-01-17 — period 2017-06-30 — FORM 10-Q
- Form 10-Q — filed 2017-11-22 — period 2017-03-31 — FORM 10-Q
- Form 8-K — filed 2017-10-30 — period 2017-10-25 — FORM 8-K
- Form 10-K/A — filed 2017-10-19 — period 2016-12-31 — FORM 10-K/A
- Form 8-K — filed 2017-10-19 — period 2017-10-05 — FORM 8-K
- Form 10-K — filed 2017-09-20 — period 2016-12-31 — FORM 10-K
- Form 8-K — filed 2017-02-15 — period 2017-02-07 — FORM 8-K CURRENT REPORT
- Form 10-Q — filed 2017-01-06 — period 2016-09-30 — FORM 10-Q QUARTERLY REPORT
- Form 10-Q — filed 2016-11-18 — period 2016-06-30 — FORM 10-Q QUARTERLY REPORT
- Form 8-K — filed 2016-11-17 — period 2016-06-29 — FORM 8-K CURRENT REPORT
- Form 10-K/A — filed 2016-11-07 — period 2016-05-31 — FORM 10-K/A AMENDED ANNUAL REPORT

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/proto-script-pharmaceutical-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology